Blue Goo Pain Relieving

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of muscle aches, pains, and strains, as well as arthritic pain, joint pain, and tendonitis.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 6 years of age and older are instructed to apply the medication liberally to the affected area, not exceeding 3 to 4 applications per day. For children under 6 years of age, the use of this medication is not recommended.

Healthcare professionals should ensure that patients are aware of the appropriate application technique and frequency to optimize therapeutic outcomes while minimizing the risk of adverse effects.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

The product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes to prevent irritation or injury. It is imperative that the product not be applied to wounds or damaged skin, as this may exacerbate the condition or lead to adverse effects.

Patients should be instructed not to bandage the area tightly after application, as this could impede circulation and lead to complications. Additionally, the use of heating pads or other heating devices in conjunction with this product is contraindicated, as it may increase the risk of skin irritation or burns.

Healthcare providers should counsel patients to discontinue use and seek medical advice under the following circumstances: if the condition worsens, if symptoms persist for 7 days or more, if symptoms resolve and then recur within a few days, or if pain, swelling, or redness develops after continued use. Monitoring for these signs is essential to ensure patient safety and effective management of their condition.

Side Effects

Patients should be aware that the product is intended for external use only. It is crucial to avoid contact with the eyes, as this may lead to irritation or other adverse effects. The product should not be applied to wounds or damaged skin, and care should be taken to avoid tight bandaging after application. Additionally, the use of heating pads or other heating devices in conjunction with this product is not recommended.

In the event that the condition worsens, or if symptoms persist for 7 days or more, patients are advised to discontinue use and consult a healthcare professional. Furthermore, if symptoms clear up and then recur within a few days, or if pain, swelling, or redness occurs after continued use, it is essential to seek medical advice. These precautions are important to ensure the safety and well-being of patients using this product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Blue Goo Pain Relieving (menthol 2.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 years and older may apply the medication liberally to the affected area up to 3-4 times daily. The safety and efficacy of this medication have not been established in children under 6 years of age; therefore, its use is not recommended in this population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. There may be potential risks to the fetus; therefore, use should be avoided unless clearly needed and prescribed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

It is crucial to document any instances of overdose and report them to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with unauthorized access to the medication, ensuring that patients understand the necessity of proper storage practices.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. Additionally, the product must be protected from light exposure to prevent degradation.

To ensure optimal preservation, the container should be kept tightly closed when not in use. It is important to note that the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

Patients aged 6 years and older are advised to apply the medication liberally to the affected area, not exceeding 3-4 times daily. The use of this medication is not recommended for children under 6 years of age. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Blue Goo Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)